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Background
Antimicrobial resistance resulted in international accordance 
to strengthen the research to investigate novel treatment 
 options  including medicinal plants. To investigate the effect of 
two  dosages of an orally hydro-ethanolic Echinacea purpurea 
(L.)  MOENCH spissum extract (EP) on performance, clinical 
health, antibody production, red and white blood cell count and 
 expression of immunological parameters in calves, a double- 
blinded placebo- controlled clinical trial has been performed.
Material and Methods
The calves were randomly enrolled in three groups (each n = 9): placebo (1) and two 
doses of EP (0,3 g EP/days: 2; 3 g EP/day: 3). The animals were vaccinated twice 
with a bluetongue virus (BTV) vaccine, serotype 4 on day 14 and 21 and were brought 
to a new farm on day 28. Body weight (weekly), clinical health and milk intake (daily) 
were recorded. Blood samples were analysed with ELISA for BTV antibodies  
(day 14, 21, 28 and 56), white and red blood cell count (weekly) by flow cytome-
try and for the mRNA abundance of a variety of inflammatory factors via real time 
 quantitative PCR (directly before and 24 hours after vaccinations) (Figure 1).
 
Results
Preliminary findings based on least square means (using  linear 
mixed effect models and Tukey's post-hoc analysis in the R en-
vironment version 3.2.5) show that EP reduced the days of diar-
rhoea in group 2 compared to 1 for 44 % (p = 0.03; Figure 2) 
and increased the body temperature in EP calves on day 28, 
29 and 32 significantly. No effect of EP was found on blood 
cell counts, except for mean eosinophil granulocytes which were 
reduced in the group 2 compared to 1 (p = 0.01). Milk intake, 
weight gain, incidence of respiratory diseases and drug con-
sumption as well as mRNA abundance of IL-1β and -8, TNFα 
and COX II showed no differences. However, mRNA abun-
dance of prostaglandin-synthase was significantly increased in 
group 2 and 3 compared to 1 after 1. vaccination. The effect of 
EP on BTV antibody production could not be interpreted, due to 
the fact that 13 of 27 calves have received BTV antibodies  
before the first vaccination from their mothers, vaccinated the last 
time 6 years before (Figure 3 [Ayrle et al., 2018]).
Discussion
Measured effects might be due to immune modulation of EP 
known from the literature (Ayrle et al., 2016). Diarrhoea reducing 
effects might be explained by stimulation of the local enteric im-
mune system of calves by EP. There is a need for further research 
focused on the effects of EP in bovines to draw final conclusions. 
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Effects of an oral Echinacea purpurea  
alcoholic spissum extract in calves 
A placebo-controlled, randomized, double blinded study
The colostral transmission of BTV antibodies from dams to calves 
6 years after vaccination has been proven for the first time  
(Ayrle et al., 2018).
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